Efficacy of Postoperative Radiotherapy in Patients With Multiple Postoperative N2 Metastases From Non-Small Cell Lung Cancer in the Immunotherapy Era: A Multicenter Prospective Controlled Phase II Clinical Trial
Latest Information Update: 20 Jan 2026
At a glance
- Drugs Antineoplastics (Primary) ; Tislelizumab (Primary)
- Indications Cancer metastases; Non-small cell lung cancer
- Focus Therapeutic Use
Most Recent Events
- 20 Jan 2026 New trial record